Oncobiologics and JSR Life Sciences publish a poster on Trastuzumab purification

In a joint effort, Oncobiologics INC and JSR Life Sciences released a poster on the optimization of a Protein A Chromatography Process for a Herceptin® Biosimilar (Trastuzumab). Four Protein A resins from leading industry vendors, including AmsphereTM A3, were screened for use in the capture step for a Trastuzumab and multiple parameters were assessed for their performance against the platform resin. Please find more details in this blog or download the poster.

Topics: Insider